Sean McCutcheon
Stock Analyst at Raymond James
(2.35)
# 2,596
Out of 5,131 analysts
12
Total ratings
45.45%
Success rate
4.27%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Sean McCutcheon
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBOT BridgeBio Oncology Therapeutics | Initiates: Outperform | $24 | $12.67 | +89.42% | 1 | Jan 9, 2026 | |
| RVMD Revolution Medicines | Maintains: Strong Buy | $72 → $76 | $117.17 | -35.14% | 2 | Oct 17, 2025 | |
| VIR Vir Biotechnology | Initiates: Outperform | $12 | $5.92 | +102.70% | 1 | Jul 11, 2025 | |
| JANX Janux Therapeutics | Initiates: Outperform | $65 | $14.03 | +363.29% | 1 | Jul 11, 2025 | |
| CMPX Compass Therapeutics | Reinstates: Outperform | $9 | $5.21 | +72.74% | 1 | Jul 1, 2025 | |
| BDTX Black Diamond Therapeutics | Reinstates: Outperform | $11 | $2.64 | +316.67% | 1 | Jul 1, 2025 | |
| ENGN enGene Holdings | Initiates: Outperform | $23 | $8.30 | +177.11% | 1 | Nov 27, 2024 | |
| XNCR Xencor | Maintains: Strong Buy | $58 → $40 | $14.17 | +182.29% | 1 | Jun 14, 2024 | |
| CYTK Cytokinetics | Maintains: Outperform | $92 → $70 | $64.64 | +8.29% | 2 | May 23, 2024 | |
| LEGN Legend Biotech | Initiates: Outperform | $86 | $23.70 | +262.87% | 1 | Mar 13, 2024 |
BridgeBio Oncology Therapeutics
Jan 9, 2026
Initiates: Outperform
Price Target: $24
Current: $12.67
Upside: +89.42%
Revolution Medicines
Oct 17, 2025
Maintains: Strong Buy
Price Target: $72 → $76
Current: $117.17
Upside: -35.14%
Vir Biotechnology
Jul 11, 2025
Initiates: Outperform
Price Target: $12
Current: $5.92
Upside: +102.70%
Janux Therapeutics
Jul 11, 2025
Initiates: Outperform
Price Target: $65
Current: $14.03
Upside: +363.29%
Compass Therapeutics
Jul 1, 2025
Reinstates: Outperform
Price Target: $9
Current: $5.21
Upside: +72.74%
Black Diamond Therapeutics
Jul 1, 2025
Reinstates: Outperform
Price Target: $11
Current: $2.64
Upside: +316.67%
enGene Holdings
Nov 27, 2024
Initiates: Outperform
Price Target: $23
Current: $8.30
Upside: +177.11%
Xencor
Jun 14, 2024
Maintains: Strong Buy
Price Target: $58 → $40
Current: $14.17
Upside: +182.29%
Cytokinetics
May 23, 2024
Maintains: Outperform
Price Target: $92 → $70
Current: $64.64
Upside: +8.29%
Legend Biotech
Mar 13, 2024
Initiates: Outperform
Price Target: $86
Current: $23.70
Upside: +262.87%